vs
C4 Therapeutics, Inc.（CCCC）与FVCBankcorp, Inc.（FVCB）财务数据对比。点击上方公司名可切换其他公司
FVCBankcorp, Inc.的季度营收约是C4 Therapeutics, Inc.的1.5倍（$16.9M vs $11.0M），FVCBankcorp, Inc.同比增速更快（4377.5% vs 112.8%），过去两年FVCBankcorp, Inc.的营收复合增速更高（586.6% vs 90.4%）
C4 Therapeutics是一家临床阶段生物制药企业，专注于开发靶向蛋白降解疗法，用于治疗癌症及其他存在重大未满足医疗需求的严重疾病。公司依托自有专利TORPEDO平台设计小分子降解剂清除致病蛋白，目前拥有多条肿瘤领域研发管线，并与头部制药企业达成战略合作。
FVCBankcorp是总部位于美国弗吉尼亚州的银行控股公司，旗下运营社区银行FVCbank，面向大西洋中部地区的中小企业、专业人士及个人客户提供存款、贷款、按揭、财富管理等各类个人及商业银行金融服务。
CCCC vs FVCB — 直观对比
营收规模更大
FVCB
是对方的1.5倍
$11.0M
营收增速更快
FVCB
高出4264.7%
112.8%
两年增速更快
FVCB
近两年复合增速
90.4%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $11.0M | $16.9M |
| 净利润 | $-20.5M | — |
| 毛利率 | — | — |
| 营业利润率 | -210.1% | 43.7% |
| 净利率 | -186.0% | — |
| 营收同比 | 112.8% | 4377.5% |
| 净利润同比 | 40.7% | — |
| 每股收益（稀释后） | $-0.09 | $0.31 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CCCCFVCB
| Q4 25 | $11.0M | $16.9M | ||
| Q3 25 | $11.2M | $416.0K | ||
| Q2 25 | $6.5M | $15.8M | ||
| Q1 25 | $7.2M | $382.0K | ||
| Q4 24 | $5.2M | $378.0K | ||
| Q3 24 | $15.4M | $412.0K | ||
| Q2 24 | $12.0M | $415.0K | ||
| Q1 24 | $3.0M | $359.0K |
净利润CCCCFVCB
| Q4 25 | $-20.5M | — | ||
| Q3 25 | $-32.2M | $5.6M | ||
| Q2 25 | $-26.0M | $5.7M | ||
| Q1 25 | $-26.3M | $5.2M | ||
| Q4 24 | $-34.6M | — | ||
| Q3 24 | $-24.7M | $4.7M | ||
| Q2 24 | $-17.7M | $4.2M | ||
| Q1 24 | $-28.4M | $1.3M |
营业利润率CCCCFVCB
| Q4 25 | -210.1% | 43.7% | ||
| Q3 25 | -306.4% | — | ||
| Q2 25 | -441.0% | 45.9% | ||
| Q1 25 | -402.9% | — | ||
| Q4 24 | -728.4% | — | ||
| Q3 24 | -183.9% | — | ||
| Q2 24 | -178.6% | — | ||
| Q1 24 | -1060.2% | — |
净利率CCCCFVCB
| Q4 25 | -186.0% | — | ||
| Q3 25 | -286.4% | 1341.1% | ||
| Q2 25 | -402.6% | 36.0% | ||
| Q1 25 | -363.7% | 1352.1% | ||
| Q4 24 | -667.8% | — | ||
| Q3 24 | -160.6% | 1133.3% | ||
| Q2 24 | -147.6% | 1001.2% | ||
| Q1 24 | -933.2% | 373.3% |
每股收益（稀释后）CCCCFVCB
| Q4 25 | $-0.09 | $0.31 | ||
| Q3 25 | $-0.44 | $0.31 | ||
| Q2 25 | $-0.37 | $0.31 | ||
| Q1 25 | $-0.37 | $0.28 | ||
| Q4 24 | $-0.50 | $0.27 | ||
| Q3 24 | $-0.35 | $0.25 | ||
| Q2 24 | $-0.26 | $0.23 | ||
| Q1 24 | $-0.41 | $0.07 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $74.6M | — |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $256.6M | $253.6M |
| 总资产 | $359.1M | $2.3B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资CCCCFVCB
| Q4 25 | $74.6M | — | ||
| Q3 25 | $58.8M | — | ||
| Q2 25 | $78.2M | — | ||
| Q1 25 | $51.3M | — | ||
| Q4 24 | $55.5M | — | ||
| Q3 24 | $59.6M | — | ||
| Q2 24 | $73.1M | — | ||
| Q1 24 | $89.7M | — |
股东权益CCCCFVCB
| Q4 25 | $256.6M | $253.6M | ||
| Q3 25 | $154.4M | $249.8M | ||
| Q2 25 | $174.1M | $243.2M | ||
| Q1 25 | $195.1M | $242.3M | ||
| Q4 24 | $216.0M | $235.4M | ||
| Q3 24 | $242.7M | $230.8M | ||
| Q2 24 | $247.1M | $226.5M | ||
| Q1 24 | $258.3M | $220.7M |
总资产CCCCFVCB
| Q4 25 | $359.1M | $2.3B | ||
| Q3 25 | $265.5M | $2.3B | ||
| Q2 25 | $296.5M | $2.2B | ||
| Q1 25 | $319.5M | $2.2B | ||
| Q4 24 | $349.6M | $2.2B | ||
| Q3 24 | $376.1M | $2.3B | ||
| Q2 24 | $381.1M | $2.3B | ||
| Q1 24 | $398.4M | $2.2B |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-22.1M | $23.9M |
| 自由现金流经营现金流 - 资本支出 | — | $23.8M |
| 自由现金流率自由现金流/营收 | — | 140.7% |
| 资本支出强度资本支出/营收 | — | 0.3% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | $40.0M |
8季度趋势，按日历期对齐
经营现金流CCCCFVCB
| Q4 25 | $-22.1M | $23.9M | ||
| Q3 25 | $-31.2M | $7.6M | ||
| Q2 25 | $-12.1M | $3.3M | ||
| Q1 25 | $-33.3M | $5.4M | ||
| Q4 24 | $-17.9M | $18.2M | ||
| Q3 24 | $-24.1M | $4.7M | ||
| Q2 24 | $-5.0M | $1.6M | ||
| Q1 24 | $-18.1M | $7.2M |
自由现金流CCCCFVCB
| Q4 25 | — | $23.8M | ||
| Q3 25 | $-31.6M | $7.6M | ||
| Q2 25 | — | $3.3M | ||
| Q1 25 | — | $5.4M | ||
| Q4 24 | $-17.9M | $18.1M | ||
| Q3 24 | $-24.1M | $4.6M | ||
| Q2 24 | $-5.2M | $1.5M | ||
| Q1 24 | — | $7.1M |
自由现金流率CCCCFVCB
| Q4 25 | — | 140.7% | ||
| Q3 25 | -281.5% | 1818.0% | ||
| Q2 25 | — | 20.8% | ||
| Q1 25 | — | 1413.6% | ||
| Q4 24 | -346.5% | 4786.0% | ||
| Q3 24 | -157.2% | 1121.8% | ||
| Q2 24 | -43.1% | 361.2% | ||
| Q1 24 | — | 1988.3% |
资本支出强度CCCCFVCB
| Q4 25 | — | 0.3% | ||
| Q3 25 | 3.7% | 0.2% | ||
| Q2 25 | — | 0.1% | ||
| Q1 25 | — | 4.2% | ||
| Q4 24 | 0.1% | 37.3% | ||
| Q3 24 | 0.1% | 14.1% | ||
| Q2 24 | 1.6% | 12.8% | ||
| Q1 24 | 0.0% | 3.9% |
现金转化率CCCCFVCB
| Q4 25 | — | — | ||
| Q3 25 | — | 1.36× | ||
| Q2 25 | — | 0.58× | ||
| Q1 25 | — | 1.05× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 1.00× | ||
| Q2 24 | — | 0.37× | ||
| Q1 24 | — | 5.34× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
